$1.72
+0.16 (+10.26%)
Analyst Consensus
Strong Buy
6
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,482.6% upside
Low Target
$16.99
Average Target
$27.22
High Target
$37.92
Current Price
$1.72
Current
$1.72
$1.72
Target
$27.22
$27.22
$16.99
$27.22 avg
$37.92
Scenario Analysis
Bear Case
$16.99
887.8%
Low target
Base Case
$27.22
+1,482.6%
Avg target
Bull Case
$37.92
+2,104.7%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$7.92
-78.3% from high
52-Week Low
$1.22
+41.0% from low
Target vs 52W High
$27.22
+243.7% vs high
Next Earnings Report
May 19, 2026
2d
until earnings
EPS Est: $-0.44
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 40 | 75% | $257.58 | +22.4% |
| AMGN | Hold | 44 | 48% | $190.87 | -41.5% |
| GILD | Strong Buy | 39 | 79% | $362.68 | +179.9% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | +0.3% |
| REGN | Strong Buy | 38 | 79% | $76.80 | -89.0% |
| ALNY | Strong Buy | 36 | 75% | $102.31 | -64.3% |
| RVMD | Strong Buy | 27 | 96% | $114.11 | -21.7% |
| BIIB | Buy | 43 | 56% | $91.45 | -52.6% |